Testimonials
Here is What Some of the Leaders of the Field Have to Say About this Meeting:
“I see this meeting as a great opportunity to connect with leaders in the Molecular Glue field to exchange thoughts and ideas on the latest breakthroughs and future directions”
Amine Sadok, Director-Induced Proximity Platform, Amgen
“There are many challenges in the molecular glue space that require new ideas, technologies, and methods to move more glues into the clinic. It is exciting to attend a conference focused on overcoming some of these challenges while getting an overview of the current R&D landscape”
Andres Hernandez de la Peña, Associate Principal Scientist, Neomorph
“This meeting is the perfect event to get in contact with both industry and academia peers in the molecular glue field and to expose and discuss new data and findings to foster the progress of the entire community”
Christian Ottmann, Founder & Chief Technical Officer, Ambagon Therapeutics
“The molecular glue degrader field is still in its infancy and in order to accelerate molecular glue discovery and development towards the clinic it is vital to bring the experts together to discuss the latest advances and share their thoughts”
Douglas Thomson, Head of Medicinal Chemistry, Proxygen
“This meeting is an excellent opportunity to hear the latest relevant research, reconnect with previous co-workers, and meet new colleagues, all of which facilitate initiating partnerships to accelerate scientific and therapeutic discoveries”
Ingrid Wertz, Chief Executive Officer & Co-Founder, Lyterian Therapeutics